Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled Study of Combination Therapy for Safety and Efficacy in Subjects With Uncomplicated Obesity

NCT00364871 is registered in ClinicalTrials.gov with Orexigen Therapeutics, Inc as lead sponsor.

NCT NCT00364871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00364871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled Study of Combination Therapy for Safety and Efficacy in Subjects With Uncomplicated Obesity
Lead sponsor
Orexigen Therapeutics, Inc
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
March 31, 2007
Enrollment
410 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

obesity